819 related articles for article (PubMed ID: 18064633)
21. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse.
Zaccone P; Phillips J; Conget I; Cooke A; Nicoletti F
Clin Immunol; 2005 Apr; 115(1):74-9. PubMed ID: 15870024
[TBL] [Abstract][Full Text] [Related]
22. Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production.
Stosić-Grujicić S; Maksimović D; Badovinac V; Samardzić T; Trajković V; Lukić M; Mostarica Stojković M
J Autoimmun; 2001 Feb; 16(1):47-58. PubMed ID: 11221996
[TBL] [Abstract][Full Text] [Related]
23. Impact of plastic adhesion in vitro on analysis of Th1 and Th2 cytokines and immune cell distribution from mice with multiple low-dose streptozotocin-induced diabetes.
Thorvaldson L; Johansson SE; Höglund P; Sandler S
J Immunol Methods; 2005 Dec; 307(1-2):73-81. PubMed ID: 16263129
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Arafat HA; Lada E; Katakam AK; Amin N
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):555-62. PubMed ID: 17177137
[TBL] [Abstract][Full Text] [Related]
25. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
Fukuda K; Tesch GH; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2008 Feb; 366(3):710-6. PubMed ID: 18082135
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.
Ishikawa H; Ochi H; Chen ML; Frenkel D; Maron R; Weiner HL
Diabetes; 2007 Aug; 56(8):2103-9. PubMed ID: 17456848
[TBL] [Abstract][Full Text] [Related]
27. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.
Sanchez-Zamora Y; Terrazas LI; Vilches-Flores A; Leal E; Juárez I; Whitacre C; Kithcart A; Pruitt J; Sielecki T; Satoskar AR; Rodriguez-Sosa M
FASEB J; 2010 Jul; 24(7):2583-90. PubMed ID: 20203087
[TBL] [Abstract][Full Text] [Related]
28. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.
Rothe H; Jenkins NA; Copeland NG; Kolb H
J Clin Invest; 1997 Feb; 99(3):469-74. PubMed ID: 9022080
[TBL] [Abstract][Full Text] [Related]
29. Role of macrophage migration inhibitory factor in corneal neovascularization.
Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
[TBL] [Abstract][Full Text] [Related]
30. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
31. Interactions of T helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells.
Schurigt U; Pfirschke C; Irmler IM; Hückel M; Gajda M; Janik T; Baumgrass R; Bernhagen J; Bräuer R
Arthritis Rheum; 2008 Oct; 58(10):3030-40. PubMed ID: 18821693
[TBL] [Abstract][Full Text] [Related]
32. Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice.
Stosić-Grujicić S; Cvjetićanin T; Stojanović I
Mol Immunol; 2009 Nov; 47(1):79-86. PubMed ID: 19211146
[TBL] [Abstract][Full Text] [Related]
33. Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction.
Paiva CN; Arras RH; Magalhães ES; Alves LS; Lessa LP; Silva MH; Ejzemberg R; Canetti C; Bozza MT
J Leukoc Biol; 2009 May; 85(5):855-61. PubMed ID: 19188484
[TBL] [Abstract][Full Text] [Related]
34. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
[TBL] [Abstract][Full Text] [Related]
35. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
Lin B; Zhang ZL; Yu LY; Guo LH
Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
[TBL] [Abstract][Full Text] [Related]
36. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
[TBL] [Abstract][Full Text] [Related]
37. Prevention of type 1 diabetes: from the view point of beta cell damage.
Kawasaki E; Abiru N; Eguchi K
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S27-32. PubMed ID: 15563975
[TBL] [Abstract][Full Text] [Related]
38. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant.
Hartmann B; Bellmann K; Ghiea I; Kleemann R; Kolb H
Diabetologia; 1997 Aug; 40(8):902-9. PubMed ID: 9267984
[TBL] [Abstract][Full Text] [Related]
39. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse.
Hadaya K; Kared H; Masson A; Chatenoud L; Zavala F
J Autoimmun; 2005 Mar; 24(2):125-34. PubMed ID: 15829405
[TBL] [Abstract][Full Text] [Related]
40. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria.
Roger T; Glauser MP; Calandra T
J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
